Position in OGN
as of Jun 30, 2026
· filed Aug 12, 2026
Position Value
$520,257
+$299,711 QoQ
Shares Held
38,424
+4.4% QoQ
Ownership
0.015%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#186
of 626 holders
Holding Since
Jun 2021
21 quarters on record
Voting authority
Sole 75%
Shared 0%
None 25%
Common Shares in OGN Over Time
Shares Held
Position Value (USD)
Derivatives in OGN
reported options exposure · as of Dec 31, 2025CallValue
$0
CallShares
0
PutValue
$1,075,500
PutShares
150,000
Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026BANK OF MONTREAL /CAN/ holds $6,780,882,947 across 16 Drug Manufacturers - General names. OGN ranks #16 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
1,724,702 | $2,068,659,488 | |
| 2 | JNJ |
Johnson & Johnson
|
4,646,972 | $1,180,191,474 | |
| 3 | ABBV |
AbbVie Inc.
|
3,470,007 | $873,192,557 | |
| 4 | MRK |
Merck & Co., Inc.
|
5,565,728 | $715,196,045 | |
| 5 | GILD |
Gilead Sciences, Inc.
|
3,772,428 | $476,608,548 | |
| 6 | AZN |
Astrazeneca PLC
|
2,359,807 | $447,466,599 | |
| 7 | AMGN |
Amgen Inc
|
882,230 | $319,473,122 | |
| 8 | GSK |
GSK plc
|
4,042,863 | $211,926,875 |
All Filings in OGN
Export CSV
22 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $520,257 | 38,424 | Shares | Defined | 2026-08-12 | |
| 2026-03-31 | $220,546 | 36,820 | Shares | Defined | 2026-05-13 | |
| 2025-12-31 | $250,709 | 34,967 | Shares | Defined | 2026-02-12 | |
| 2025-12-31 | $1,075,500 | 150,000 | Put | Defined | 2026-02-12 | |
| 2025-09-30 | $407,162 | 38,124 | Shares | Defined | 2025-11-13 | |
| 2025-06-30 | $650,513 | 67,202 | Shares | Defined | 2025-08-05 | |
| 2025-03-31 | $1,008,824 | 67,752 | Shares | Defined | 2025-05-13 | |
| 2024-12-31 | $888,558 | 59,555 | Shares | Defined | 2025-02-13 | |
| 2024-09-30 | $1,750,392 | 91,500 | Shares | Defined | 2024-11-13 | |
| 2024-06-30 | $1,291,305 | 62,382 | Shares | Defined | 2024-08-14 | |
| 2024-03-31 | $1,352,563 | 71,945 | Shares | Defined | 2024-05-13 | |
| 2023-12-31 | $1,455,695 | 100,950 | Shares | Defined | 2024-02-08 | |
| 2023-09-30 | $2,763,935 | 159,213 | Shares | Defined | 2023-11-01 | |
| 2023-06-30 | $7,377,204 | 354,503 | Shares | Defined | 2023-08-02 | |
| 2023-03-31 | $2,589,550 | 110,100 | Shares | Defined | 2024-06-13 | |
| 2022-12-31 | $9,896,770 | 354,342 | Shares | Defined | 2023-02-01 | |
| 2022-09-30 | $5,668,483 | 242,243 | Shares | Defined | 2022-11-10 | |
| 2022-06-30 | $9,195,791 | 272,468 | Shares | Defined | 2022-08-11 | |
| 2022-03-31 | $9,268,357 | 265,341 | Shares | Defined | 2022-05-12 | |
| 2021-12-31 | $10,453,573 | 343,303 | Shares | Defined | 2022-02-11 | |
| 2021-09-30 | $16,529,041 | 504,088 | Shares | Defined | 2021-11-12 | |
| 2021-06-30 | $13,194,505 | 436,038 | Shares | Defined | 2021-08-12 | |
| No filing history on record for this holder in this stock. | ||||||